Presenter: Oliver Grundman, PhD
Original Date: July 20, 2024

Kratom, a tree native to Southeast Asia also known by its Latin name Mitragyna speciosa, has gained substantial public interest in the US as a botanical product. Its alkaloids act on a number of receptor systems, including opioid, adrenergic, and serotonergic receptors leading to a complex pharmacology. The traditional use in Southeast Asia has not been reported to result in a use disorder although kratom extracts and concentrates sold in the US may lead to tolerance and dependence with frequent and high-dose consumption. This presentation focuses on the pharmacology, reported self-treatment of disorders, and detrimental or toxic effects of kratom.

NUNM is accredited by the North American Naturopathic Continuing Education Council (NANCEAC). This activity qualifies for 1.5 Pharmacology CEUs.